» Articles » PMID: 29917188

Mechanism of LncRNA DUXAP8 in Promoting Proliferation of Bladder Cancer Cells by Regulating PTEN

Overview
Date 2018 Jun 20
PMID 29917188
Citations 27
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To evaluate the lncRNA DUXAP8 expression in bladder cancer and its mechanism.

Patients And Methods: Clinical specimens were analyzed. The expression of lncRNA in bladder cancer and adjacent tissues was detected using qRT-PCR. The χ2-test analysis was used to analyze the relationship between lncRNA DUXAP8 expression and clinicopathological information in patients with bladder cancer. The tumor cell activity and cell proliferation were measured by cell counting kit-8 (CCK8) and colony formation assay. We utilized polymerase chain reaction (PCR) to access PTEN expression in bladder cancer and adjacent tissues. Pearson correlation analysis was utilized for evaluating the relationship between PTEN and lncRNA DUXAP8. Western blot was used for detecting protein expression.

Results: LncRNA DUXAP8 expression was higher in bladder cancer tissues; it was in a positive correlation with the TNM stage and tumor size, but negatively correlated with the total survival time. Knockdown of DUXAP8 decreased cell viability and cellular proliferation. Lower expression of PTEN gene was found in bladder cancer compared with that in adjacent tissues. Pearson correlation analysis showed that PTEN was negatively correlated with DUXAP8; knockdown of DUAP8 increased the expression of PTEN. Overexpressing DUAP8 increased protein level of PTEN, but decreased cell viability.

Conclusions: Our results pointed out that lncRNA DUXAP8 was overexpressed in bladder cancer tissues, which can promote the progression of bladder cancer through inhibiting PTEN.

Citing Articles

Overexpression of long noncoding RNA DUXAP8 inhibits ER-phagy through activating AKT/mTOR signaling and contributes to preeclampsia.

Wei X, Liao L, Yin Y, Xu Q, Xie S, Liu M Cell Mol Life Sci. 2024; 81(1):336.

PMID: 39120751 PMC: 11335266. DOI: 10.1007/s00018-024-05385-y.


Tumorigenesis of basal muscle invasive bladder cancer was mediated by PTEN protein degradation resulting from SNHG1 upregulation.

Li T, Huang M, Sun N, Hua X, Chen R, Xie Q J Exp Clin Cancer Res. 2024; 43(1):50.

PMID: 38365726 PMC: 10874020. DOI: 10.1186/s13046-024-02966-4.


Long non-coding RNAs as the critical regulators of PI3K/AKT, TGF-β, and MAPK signaling pathways during breast tumor progression.

Maharati A, Moghbeli M J Transl Med. 2023; 21(1):556.

PMID: 37596669 PMC: 10439650. DOI: 10.1186/s12967-023-04434-7.


The Impact of the Initial Clinical Presentation of Bladder Cancer on Histopathological and Morphological Tumor Characteristics.

Jakus D, Solic I, Juric I, Borovac J, Situm M J Clin Med. 2023; 12(13).

PMID: 37445294 PMC: 10342402. DOI: 10.3390/jcm12134259.


LncRNA DUXAP8 induces breast cancer radioresistance by modulating the PI3K/AKT/mTOR pathway and the EZH2-E-cadherin/RHOB pathway.

Lei C, Li S, Fan Y, Hua L, Pan Q, Li Y Cancer Biol Ther. 2022; 23(1):1-13.

PMID: 36329030 PMC: 9635553. DOI: 10.1080/15384047.2022.2132008.